title: Rituximab-related urticarial reaction in a patient treated for primary cutaneous B-cell lymphoma.
authors.forename: D
authors.initials: D
authors.lastname: Errante
authors.forename: D
authors.initials: D
authors.lastname: Bernardi
authors.forename: A
authors.initials: A
authors.lastname: Bianco
authors.forename: S
authors.initials: S
authors.lastname: De Nardi
authors.forename: L
authors.initials: L
authors.lastname: Salvagno
mesh_terms: D000328:Adult; D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D016393:Lymphoma, B-Cell / Q000188:drug therapy*; D008297:Male; D051379:Mice; D000069283:Rituximab; D012878:Skin Neoplasms / Q000188:drug therapy*; D014581:Urticaria / Q000139:chemically induced*
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000970:Antineoplastic Agents; D000069283:Rituximab